Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda R Valsdottir

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Ecology and Evolution|March 7, 2017
A parasite's modification of host behavior reduces predation on its hostJohn Soghigian, Linda R Valsdottir, Todd P Livdahl
Briefings in Bioinformatics|May 6, 2020
Identifying drug-target interactions based on graph convolutional network and deep neural networkTianyi Zhao, Yang Hu, Linda R Valsdottir, et al.
Circulation. Cardiovascular Quality and Outcomes|January 13, 2021
Rationale and Design of the SAFE-PAD StudyEric A Secemsky, Aishwarya Raja, Changyu Shen, et al.
The American Journal of Cardiology|March 10, 2020
Relation of Frailty to Outcomes After Catheter Ablation of Atrial FibrillationHarun Kundi, Peter A Noseworthy, Linda R Valsdottir, et al.
JAMA Cardiology|September 26, 2019
Association of Frailty With 30-Day Outcomes for Acute Myocardial Infarction, Heart Failure, and Pneumonia Among Elderly AdultsHarun Kundi, Rishi K Wadhera, Jordan B Strom, et al.
The Canadian Journal of Cardiology|December 12, 2018
The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip ProcedureHarun Kundi, Jeffrey J Popma, Linda R Valsdottir, et al.
JACC. Cardiovascular Interventions|October 22, 2018
Trends in Isolated Surgical Aortic Valve Replacement According to Hospital-Based Transcatheter Aortic Valve Replacement VolumesHarun Kundi, Jordan B Strom, Linda R Valsdottir, et al.
Coronary Artery Disease|January 25, 2019
Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary interventionBenjamin Z Galper, Matthew R Reynolds, Pallav Garg, et al.
Circulation|September 10, 2019
Geographic Patterns of Growth for Transcatheter Aortic Valve Replacement in the United StatesHarun Kundi, Kamil F Faridi, Yun Wang, et al.
Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare BeneficiariesHarun Kundi, Linda R Valsdottir, Jeffrey J Popma, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Ecology and Evolution|March 7, 2017
A parasite's modification of host behavior reduces predation on its hostJohn Soghigian, Linda R Valsdottir, Todd P Livdahl
Briefings in Bioinformatics|May 6, 2020
Identifying drug-target interactions based on graph convolutional network and deep neural networkTianyi Zhao, Yang Hu, Linda R Valsdottir, et al.
Circulation. Cardiovascular Quality and Outcomes|January 13, 2021
Rationale and Design of the SAFE-PAD StudyEric A Secemsky, Aishwarya Raja, Changyu Shen, et al.
The American Journal of Cardiology|March 10, 2020
Relation of Frailty to Outcomes After Catheter Ablation of Atrial FibrillationHarun Kundi, Peter A Noseworthy, Linda R Valsdottir, et al.
JAMA Cardiology|September 26, 2019
Association of Frailty With 30-Day Outcomes for Acute Myocardial Infarction, Heart Failure, and Pneumonia Among Elderly AdultsHarun Kundi, Rishi K Wadhera, Jordan B Strom, et al.
The Canadian Journal of Cardiology|December 12, 2018
The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip ProcedureHarun Kundi, Jeffrey J Popma, Linda R Valsdottir, et al.
JACC. Cardiovascular Interventions|October 22, 2018
Trends in Isolated Surgical Aortic Valve Replacement According to Hospital-Based Transcatheter Aortic Valve Replacement VolumesHarun Kundi, Jordan B Strom, Linda R Valsdottir, et al.
Coronary Artery Disease|January 25, 2019
Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary interventionBenjamin Z Galper, Matthew R Reynolds, Pallav Garg, et al.
Circulation|September 10, 2019
Geographic Patterns of Growth for Transcatheter Aortic Valve Replacement in the United StatesHarun Kundi, Kamil F Faridi, Yun Wang, et al.
Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare BeneficiariesHarun Kundi, Linda R Valsdottir, Jeffrey J Popma, et al.
Pageof 3